Benchmark Maintains Buy on BlueLinx Hldgs, Raises Price Target to $83

Benzinga Newsdesk www.benzinga.com Positive 74.0%

Neg 0% Neu 0% Pos 74%

Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and raises the price target from $75 to $83.